EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Monitoring antimalarial drug-resistance markers in Somalia

Abdifatah Abdullahi Jalei, Kesara Na-Bangchang, Phunuch Muhamad, Wanna Chaijaroenkul

Parasites, Hosts and Diseases · 22.02.2023 · 61 (1) · 78-83

DOI: 10.3347/phd.22140 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Parasites, Hosts and Diseases, online erschienen am 22.02.2023. Verfasst von Abdifatah Abdullahi Jalei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chulabhorn International College of Medicine, Thammasat University, Klong Luang, Pathumthani 12120, Thailand. Hauptthemen laut MEDLINE: Antimalarials, Malaria, Falciparum, Malaria. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: National Research Council of Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of an effective antimalarial drug is the cornerstone of malaria control. However, the development and spread of resistant Plasmodium falciparum strains have placed the global eradication of malaria in serious jeopardy. Molecular marker analysis constitutes the hallmark of the monitoring of Plasmodium drug-resistance. This study included 96 P. falciparum PCR-positive samples from southern Somalia. The P. falciparum chloroquine resistance transporter gene had high frequencies of K76T, A220S, Q271E, N326S, and R371I point mutations. The N86Y and Y184F mutant alleles of the P. falciparum multidrug resistance 1 gene were present in 84.7 and 62.4% of the isolates, respectively. No mutation was found in the P. falciparum Kelch-13 gene. This study revealed that chloroquine resistance markers are present at high frequencies, while the parasite remains sensitive to artemisinin (ART). The continuous monitoring of ART-resistant markers and in vitro susceptibility testing are strongly recommended to track resistant strains in real time.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntimalarialsMalaria, FalciparumMalariaHumansSomaliaChloroquinePlasmodium falciparumArtemisinins

Stichwörter der Autor:innen

Plasmodium falciparumSouthern Somaliadrug-resistancemolecular marker

Substanzen

AntimalarialsChloroquineartemisininArtemisinins

Autor:innen und Institutionen

  • Chulabhorn International College of Medicine, Thammasat University, Klong Luang, Pathumthani 12120, Thailand.
  • Drug Discovery and Development Center, Office of Advanced Science and Technology, Thammasat University, Pathumthani 12120, Thailand.
  • Center of Excellence in Pharmacology and Molecular Biology of Malaria and Cholangiocarcinoma, Chulabhorn International College of Medicine, Thammasat University, Klong Luang, Pathumthani 12120, Thailand.

Förderung

  • National Research Council of Thailand

Zitieren

APA

Jalei, A. A., Na-Bangchang, K., Muhamad, P., & Chaijaroenkul, W. (2023). Monitoring antimalarial drug-resistance markers in Somalia. Parasites, Hosts and Diseases, 61(1), 78-83. https://doi.org/10.3347/phd.22140

Vancouver

Jalei AA, Na-Bangchang K, Muhamad P, Chaijaroenkul W. Monitoring antimalarial drug-resistance markers in Somalia. Parasites, Hosts and Diseases. 2023;61(1):78-83. doi:10.3347/phd.22140

BibTeX
@article{Jalei2023,
  author = {Jalei, Abdifatah Abdullahi and Na-Bangchang, Kesara and Muhamad, Phunuch and Chaijaroenkul, Wanna},
  title = {Monitoring antimalarial drug-resistance markers in Somalia},
  journal = {Parasites, Hosts and Diseases},
  year = {2023},
  volume = {61},
  number = {1},
  pages = {78--83},
  doi = {10.3347/phd.22140}
}
Kostenlos starten →